+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hospital-Acquired Infection Control Market by Product & Service and End User: Global Opportunity Analysis and Industry Forecast, 2022-2030

  • ID: 5439801
  • Report
  • July 2021
  • Region: Global
  • 277 Pages
  • Allied Analytics LLP

FEATURED COMPANIES

  • 3M Company
  • Belimed AG
  • Ecolab Inc
  • Getinge AB
  • Matachana Group
  • Miele Group
The global hospital-acquired infection control market was valued at $19,958 million in 2020, and is projected to reach $25,006 million by 2030, registering a CAGR of 4.6% from 2022 to 2030.



Infection can be classified into various types, which include hospital-acquired infections, ear infections, eye infections, lung & respiratory infections, skin infections, common childhood infections, sexually transmitted infections, and stomach & intestinal infections. Hospital-acquired infectious diseases are caused by viruses, bacteria, parasites, or fungi. These infections can be controlled with the help of sterilization, cleaning, & disinfection products; protective barriers; and endoscope reprocessing products. Protective barrier products include surgical gowns, face masks, and coveralls.

The growth of the global hospital-acquired infection control market is driven by rise in number of surgical procedures, increase in incidence of hospital-acquired infections, surge in geriatric population, technological advancements in sterilization equipment, and rise in incidence of chronic diseases across the globe. In addition, rise in outsourcing of sterilization services among hospitals and pharmaceutical & medical device companies boosts the growth of the market. Moreover, re-introduction of ethylene oxide sterilization, increase in use of e-beam sterilization, surge in awareness of environmental & personal hygiene due to COVID-19 acts as the key driving forces of the global market. However, adverse effects of chemical disinfectants and concerns regarding the safety of reprocessed instruments are expected to restrain the growth of the hospital-acquired infection control market. Conversely, rise in adoption of single-use medical nonwovens and devices is expected to offer lucrative opportunities during the forecast period.

The global hospital-acquired infection control market is segmented into product & service, infection type, end user, and region. On the basis of product & service, the market is categorized into sterilization, cleaning & disinfection products, protective barriers, and endoscope reprocessing products. By sterilization, it is divided into sterilization product, contract sterilization services, and sterilization consumables & accessories. The sterilization product segment is further classified into heat sterilization equipment, low temperature sterilization equipment, radiation sterilization equipment, and other sterilization equipment. Depending on cleaning & disinfection products, the market is segregated into disinfectants, disinfector equipment, and others. As per infection type, it is categorized into hospital-acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal infections, urinary tract infections (UTI), and others. According to end user, it is fragmented into hospitals & clinics, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
  • A comprehensive analysis of four regions is provided to determine the existing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS


By Product & Service

  • Sterilization
  • Sterilization Product
  • Heat Sterilization Equipment
  • Low Temperature Sterilization Equipment
  • Radiation Sterilization Equipment
  • Other Sterilization Equipment
  • Contract Sterilization Services
  • Sterilization Consumables & Accessories
  • Cleaning & Disinfection Products
  • Disinfectants
  • Disinfectors Equipment
  • Others
  • Protective Barriers
  • Endoscope Reprocessing Products

By Infection Type

  • Hospital-acquired Pneumonia
  • Bloodstream Infections
  • Surgical Site Infections
  • Gastrointestinal Infections
  • Urinary Tract Infections (UTI)
  • Others

By End User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

  • 3M Company
  • Belimed AG
  • Ecolab Inc
  • Fortive (Advanced Sterilization Products)
  • Getinge AB
  • Matachana Group
  • Miele Group
  • MMM Group
  • Sotera Health LLC
  • Steris Plc. (Cantel Medical Corporation)

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
  • Kimberly-Clark Corporation
  • Becton, Dickinson and Company
  • Synergy Health, PLC
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M Company
  • Belimed AG
  • Ecolab Inc
  • Getinge AB
  • Matachana Group
  • Miele Group

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five force analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Rise in incidence of hospital-acquired infections
3.5.1.2. Upsurge in likelihood of epidemic or pandemic outbreaks
3.5.1.3. Increase in geriatric population and rise in incidence of chronic diseases
3.5.2. Restraint
3.5.2.1. Adverse effects of chemical disinfectants
3.5.3. Opportunities
3.5.3.1. High market growth potential in emerging markets
3.5.4. Impact analysis
3.6. Covid-19 impact analysis on hospital-acquired infection control market
CHAPTER 4: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE
4.1. Overview
4.1.1. Market size and forecast
4.2. Sterilization
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.2.4. Market size and forecast, by type
4.2.4.1. Sterilization product
4.2.4.1.1. Market size and forecast, by type
4.2.4.1.1.1. Heat sterilization equipment
4.2.4.1.1.1.1. Market size and forecast
4.2.4.1.1.2. Low temperature sterilization equipment
4.2.4.1.1.2.1. Market size and forecast
4.2.4.1.1.3. Radiation sterilization equipment
4.2.4.1.1.3.1. Market size and forecast
4.2.4.1.1.4. Other sterilization equipment
4.2.4.1.1.4.1. Market size and forecast
4.2.4.2. Contract sterilization services
4.2.4.3. Sterilization consumables & accessories
4.3. Cleaning & disinfection products
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.3.4. Market size and forecast, by type
4.3.4.1. Disinfectants
4.3.4.1.1. Market size and forecast
4.3.4.2. Disinfector equipment
4.3.4.2.1. Market size and forecast
4.3.4.3. Others
4.3.4.3.1. Market size and forecast
4.4. Protective barriers
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Endoscope reprocessing products
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
CHAPTER 5: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Hospital-acquired pneumonia
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Bloodstream infections
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Surgical site infections
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Gastrointestinal infections
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country
5.6. Urinary tract infections
5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by country
5.7. Others
5.7.1. Market size and forecast, by region
5.7.2. Market analysis, by country
CHAPTER 6: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals & clinics
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Ambulatory surgical centers
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Others
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country
CHAPTER 7: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country
7.2.2.1. U. S.
7.2.2.1.1. U. S. hospital-acquired infection control market, by product & service
7.2.2.1.2. U. S. hospital-acquired infection control market, by infection type
7.2.2.1.3. U. S. hospital-acquired infection control market, by end user
7.2.2.2. Canada
7.2.2.2.1. Canada hospital-acquired infection control market, by product & service
7.2.2.2.2. Canada hospital-acquired infection control market, by infection type
7.2.2.2.3. Canada hospital-acquired infection control market, by end user
7.2.2.3. Mexico
7.2.2.3.1. Mexico hospital-acquired infection control market, by product & service
7.2.2.3.2. Mexico hospital-acquired infection control market, by infection type
7.2.2.3.3. Mexico hospital-acquired infection control market, by end user
7.2.3. North America market size and forecast, by product & service
7.2.4. North America market size and forecast, by infection type
7.2.5. North America market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country
7.3.2.1. Germany
7.3.2.1.1. Germany hospital-acquired infection control market, by product & service
7.3.2.1.2. Germany hospital-acquired infection control market, by infection type
7.3.2.1.3. Germany hospital-acquired infection control market, by end user
7.3.2.2. France
7.3.2.2.1. France hospital-acquired infection control market, by product & service
7.3.2.2.2. France hospital-acquired infection control market, by infection type
7.3.2.2.3. France hospital-acquired infection control market, by end user
7.3.2.3. UK
7.3.2.3.1. UK hospital-acquired infection control market, by product & service
7.3.2.3.2. UK hospital-acquired infection control market, by infection type
7.3.2.3.3. UK hospital-acquired infection control market, by end user
7.3.2.4. Italy
7.3.2.4.1. Italy hospital-acquired infection control market, by product & service
7.3.2.4.2. Italy hospital-acquired infection control market, by infection type
7.3.2.4.3. Italy hospital-acquired infection control market, by end user
7.3.2.5. Spain
7.3.2.5.1. Spain hospital-acquired infection control market, by product & service
7.3.2.5.2. Spain hospital-acquired infection control market, by infection type
7.3.2.5.3. Spain hospital-acquired infection control market, by end user
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe hospital-acquired infection control market, by product & service
7.3.2.6.2. Rest of Europe hospital-acquired infection control market, by infection type
7.3.2.6.3. Rest of Europe hospital-acquired infection control market, by end user
7.3.3. Europe market size and forecast, by product & service
7.3.4. Europe market size and forecast, by infection type
7.3.5. Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country
7.4.2.1. Japan
7.4.2.1.1. Japan hospital-acquired infection control market, by product & service
7.4.2.1.2. Japan hospital-acquired infection control market, by infection type
7.4.2.1.3. Japan hospital-acquired infection control market, by end user
7.4.2.2. China
7.4.2.2.1. China hospital-acquired infection control market, by product & service
7.4.2.2.2. China hospital-acquired infection control market, by infection type
7.4.2.2.3. China hospital-acquired infection control market, by end user
7.4.2.3. Australia
7.4.2.3.1. Australia hospital-acquired infection control market, by product & service
7.4.2.3.2. Australia hospital-acquired infection control market, by infection type
7.4.2.3.3. Australia hospital-acquired infection control market, by end user
7.4.2.4. India
7.4.2.4.1. India hospital-acquired infection control market, by product & service
7.4.2.4.2. India hospital-acquired infection control market, by infection type
7.4.2.4.3. India hospital-acquired infection control market, by end user
7.4.2.5. South Korea
7.4.2.5.1. South Korea hospital-acquired infection control market, by product & service
7.4.2.5.2. South Korea hospital-acquired infection control market, by infection type
7.4.2.5.3. South Korea hospital-acquired infection control market, by end user
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Rest of Asia-Pacific hospital-acquired infection control market, by product & service
7.4.2.6.2. Rest of Asia-Pacific hospital-acquired infection control market, by infection type
7.4.2.6.3. Rest of Asia-Pacific hospital-acquired infection control market, by end user
7.4.3. Asia-Pacific market size and forecast, by product & service
7.4.4. Asia-Pacific market size and forecast, by infection type
7.4.5. Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country
7.5.2.1. Brazil
7.5.2.1.1. Brazil hospital-acquired infection control market, by product & service
7.5.2.1.2. Brazil hospital-acquired infection control market, by infection type
7.5.2.1.3. Brazil hospital-acquired infection control market, by end user
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia hospital-acquired infection control market, by product & service
7.5.2.2.2. Saudi Arabia hospital-acquired infection control market, by infection type
7.5.2.2.3. Saudi Arabia hospital-acquired infection control market, by end user
7.5.2.3. South Africa
7.5.2.3.1. South Africa hospital-acquired infection control market, by product & service
7.5.2.3.2. South Africa hospital-acquired infection control market, by infection type
7.5.2.3.3. South Africa hospital-acquired infection control market, by end user
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Rest of LAMEA hospital-acquired infection control market, by product & service
7.5.2.4.2. Rest of LAMEA hospital-acquired infection control market, by infection type
7.5.2.4.3. Rest of LAMEA hospital-acquired infection control market, by end user
7.5.3. LAMEA market size and forecast, by product & service
7.5.4. LAMEA market size and forecast, by infection type
7.5.5. LAMEA market size and forecast, by end user
CHAPTER 8: COMPANY PROFILES
8.1.3M Company
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. Belimed AG.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.3. Ecolab Inc.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. Fortive Corporation (Advanced Sterilization Products).
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. Getinge AB
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. Matachana Group
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Key strategic moves and developments
8.7. Miele Group. (Steelco)
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.8. MMM Group
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.9. Sotera Health Inc.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. Steris Plc (Cantel Medical Corporation)
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
LIST OF TABLES
TABLE 01. HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 02. HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY REGION, 2020-2030 ($MILLION)
TABLE 03. HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2020-2030 ($MILLION)
TABLE 04. HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION PRODUCT, BY TYPE, 2020-2030 ($MILLION)
TABLE 05. HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY REGION, 2020-2030 ($MILLION)
TABLE 06. HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2020-2030 ($MILLION)
TABLE 07. HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY REGION, 2020-2030 ($MILLION)
TABLE 08. HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY REGION, 2020-2030 ($MILLION)
TABLE 09. HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 10. HOSPITAL-ACQUIRED PNEUMONIA CONTROL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 11. HOSPITAL-ACQUIRED BLOODSTREAM INFECTION CONTROL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 12. HOSPITAL-ACQUIRED SURGICAL SITE INFECTION CONTROL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 13. HOSPITAL-ACQUIRED GASTROINTESTINAL INFECTION CONTROL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 14. HOSPITAL-ACQUIRED URINARY TRACT INFECTION CONTROL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 15. HOSPITAL-ACQUIRED OTHER INFECTION CONTROL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 16. HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 17. HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020-2030 ($MILLION)
TABLE 18. HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2020-2030 ($MILLION)
TABLE 19. HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 20. HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 21. NORTH AMERICA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 22. U.S. HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 23. U.S. HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 24. U.S. HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 25. CANADA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 26. CANADA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 27. CANADA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 28. MEXICO HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 29. MEXICO HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 30. MEXICO HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 31. NORTH AMERICA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 32. NORTH AMERICA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 33. NORTH AMERICA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 34. EUROPE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 35. GERMANY HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 36. GERMANY HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 37. GERMANY HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 38. FRANCE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 39. FRANCE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 40. FRANCE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 41. UK HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 42. UK HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 43. UK HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 44. ITALY HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 45. ITALY HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 46. ITALY HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 47. SPAIN HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 48. SPAIN HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 49. SPAIN HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 50. REST OF EUROPE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 51. REST OF EUROPE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 52. REST OF EUROPE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 53. EUROPE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 54. EUROPE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 55. EUROPE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 56. ASIA-PACIFIC HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 57. JAPAN HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 58. JAPAN HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 59. JAPAN HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 60. CHINA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 61. CHINA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 62. CHINA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 63. AUSTRALIA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 64. AUSTRALIA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 65. AUSTRALIA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 66. INDIA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 67. INDIA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 68. INDIA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 69. SOUTH KOREA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 70. SOUTH KOREA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 71. SOUTH KOREA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 73. REST OF ASIA-PACIFIC HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 74. REST OF ASIA-PACIFIC HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 75. ASIA-PACIFIC HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 76. ASIA-PACIFIC HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 77. ASIA-PACIFIC HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 78. LAMEA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 79. BRAZIL HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 80. BRAZIL HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 81. BRAZIL HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 82. SAUDI ARABIA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 83. SAUDI ARABIA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 84. SAUDI ARABIA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 85. SOUTH AFRICA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 86. SOUTH AFRICA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 87. SOUTH AFRICA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 88. REST OF LAMEA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 89. REST OF LAMEA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 90. REST OF LAMEA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 91. LAMEA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 92. LAMEA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 93. LAMEA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 94.3M: COMPANY SNAPSHOT
TABLE 95.3M: OPERATING SEGMENTS
TABLE 96.3M: PRODUCT PORTFOLIO
TABLE 97. BELIMED: COMPANY SNAPSHOT
TABLE 98. BELIMED: OPERATING SEGMENTS
TABLE 99. BELIMED: PRODUCT PORTFOLIO
TABLE 100. ECOLAB: COMPANY SNAPSHOT
TABLE 101. ECOLAB: OPERATING SEGMENTS
TABLE 102. ECOLAB: PRODUCT PORTFOLIO
TABLE 103. FORTIVE: COMPANY SNAPSHOT
TABLE 104. FORTIVE: OPERATING SEGMENTS
TABLE 105. FORTIVE: PRODUCT PORTFOLIO
TABLE 106. GETINGE: COMPANY SNAPSHOT
TABLE 107. GETINGE: OPERATING SEGMENTS
TABLE 108. GETINGE: PRODUCT PORTFOLIO
TABLE 109. MATACHNA: COMPANY SNAPSHOT
TABLE 110. MATACHANA: OPERATING SEGMENTS
TABLE 111. MATACHANA: PRODUCT PORTFOLIO
TABLE 112. MIELE: COMPANY SNAPSHOT
TABLE 113. MIELE: OPERATING SEGMENTS
TABLE 114. MIELE: PRODUCT PORTFOLIO
TABLE 115. MMM COMPANY SNAPSHOT
TABLE 116. MMM: OPERATING SEGMENTS
TABLE 117. MMM: PRODUCT PORTFOLIO
TABLE 118. SOTERA HEALTH: COMPANY SNAPSHOT
TABLE 119. SOTERA HEALTH: OPERATING SEGMENTS
TABLE 120. SOTERA HEALTH: PRODUCT PORTFOLIO
TABLE 121. STERIS: COMPANY SNAPSHOT
TABLE 122. STERIS: OPERATING SEGMENTS
TABLE 123. STERIS: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. HOSPITAL-ACQUIRED INFECTION CONTROL MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2018-2021
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2021
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2018-2021
FIGURE 01. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 02. MODERATE BARGAINING POWER OF BUYERS
FIGURE 03. HIGH THREAT OF SUBSTITUTES
FIGURE 04. HIGH THREAT OF NEW ENTRANTS
FIGURE 05. MODERATE INTENSITY OF RIVALRY
FIGURE 06. TOP PLAYER POSITIONING, 2020
FIGURE 07. IMPACT ANALYSIS
FIGURE 08. COMPARATIVE ANALYSIS OF HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 09. HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, 2020-2030 ($MILLION)
FIGURE 10. HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR LOW TEMPERATURE STERILIZATION EQUIPMENT, 2020-2030 ($MILLION)
FIGURE 11. HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR RADIATION STERILIZATION EQUIPMENT, 2020-2030 ($MILLION)
FIGURE 12. HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR OTHER STERILIZATION EQUIPMENT, 2020-2030 ($MILLION)
FIGURE 13. COMPARATIVE ANALYSIS OF HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14. HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANTS, 2020-2030 ($MILLION)
FIGURE 15. HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTOR EQUIPMENT, 2020-2030 ($MILLION)
FIGURE 16. HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR OTHERS CLEANING & DISINFECTION PRODUCTS, 2020-2030 ($MILLION)
FIGURE 17. COMPARATIVE ANALYSIS OF HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 18. COMPARATIVE ANALYSIS OF HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 19. COMPARATIVE ANALYSIS OF HOSPITAL-ACQUIRED PNEUMONIA CONTROL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 20. COMPARATIVE ANALYSIS OF HOSPITAL-ACQUIRED BLOODSTREAM INFECTION CONTROL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 21. COMPARATIVE ANALYSIS OF HOSPITAL-ACQUIRED SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 22. COMPARATIVE ANALYSIS HOSPITAL-ACQUIRED GASTROINTESTINAL INFECTION CONTROL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 23. COMPARATIVE ANALYSIS HOSPITAL-ACQUIRED URINARY TRACT INFECTION CONTROL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 24. COMPARATIVE ANALYSIS OF HOSPITAL-ACQUIRED OTHER INFECTION CONTROL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 25. COMPARATIVE ANALYSIS OF HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 26. COMPARATIVE ANALYSIS OF HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 27. COMPARATIVE ANALYSIS OF HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR OTHERS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 28.3M:NET SALES,2018-2020 ($MILLION)
FIGURE 29.3M: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 30.3M: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 31. BELIMED:NET SALES, 2018-2020 ($MILLION)
FIGURE 32. BELIMED: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 33. BELIMED: REVENUE SHARE BY REGION 2020 (%)
FIGURE 34. ECOLAB: NET SALES, 2018-2020 ($MILLION)
FIGURE 35. ECOLAB: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 36. ECOLAB: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 37. FORTIVE: NET SALES, 2018-2020 ($MILLION)
FIGURE 38. FORTIVE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 39. FORTIVE: REVENUE SHARE BY REGION 2020 (%)
FIGURE 40. GETINGE: NET SALES, 2018-2020 ($MILLION)
FIGURE 41. GETINGE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 42. GETINGE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 43. SOTERA HEALTH: NET SALES, 2018-2020 ($MILLION)
FIGURE 44. SOTERA HEALTH: REVENUE SHARE BY SEGMENTS, 2020(%)
FIGURE 45. SOTERA HEALTH: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 46. STERIS: NET SALES, 2018-2020 ($MILLION)
FIGURE 47. STERIS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 48. STERIS: REVENUE SHARE BY REGION, 2020 (%)
Note: Product cover images may vary from those shown
  • 3M Company
  • Belimed AG
  • Ecolab Inc
  • Fortive (Advanced Sterilization Products)
  • Getinge AB
  • Matachana Group
  • Miele Group
  • MMM Group
  • Sotera Health LLC
  • Steris Plc. (Cantel Medical Corporation).
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...